Allopurinol
Brand name: Allopurinol
Rank #234 of 500 drugs by total cost
$56.9M
Total Cost
3,852,206
Total Claims
$56.9M
Total Cost
78,466
Prescribers
$15
Cost per Claim
850,618
Beneficiaries
9,160,297
30-Day Fills
$725
Avg Cost/Provider
49
Avg Claims/Provider
About Allopurinol
Allopurinol (sold as Allopurinol) was prescribed 3,852,206 times by 78,466 Medicare Part D providers in 2023, costing the program $56.9M. At $15 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 231 | Somatropin (Genotropin) | $57.4M | 8,552 |
| 232 | Lumateperone Tosylate (Caplyta) | $57.4M | 35,791 |
| 233 | Everolimus (Everolimus) | $57.0M | 8,962 |
| 234 | Allopurinol (Allopurinol) | $56.9M | 3,852,206 |
| 235 | Exenatide Microspheres (Bydureon Bcise) | $56.6M | 48,670 |
| 236 | Valsartan (Valsartan) | $56.4M | 1,481,937 |
| 237 | Benralizumab (Fasenra Pen) | $54.8M | 9,334 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology